Copyright Reports & Markets. All rights reserved.

Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Product
      • 1.4.2 CMX-020
      • 1.4.3 CA-016
      • 1.4.4 DD-04107
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by End User
      • 1.5.2 Ophthalmology
      • 1.5.3 Immunology
      • 1.5.4 Muscle Spasm
      • 1.5.5 Pruritus
      • 1.5.6 Abdominal Pain
      • 1.5.7 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size
      • 2.1.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue 2014-2025
      • 2.1.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales 2014-2025
    • 2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Growth Rate by Regions
      • 2.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales by Regions
      • 2.2.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales by Manufacturers
      • 3.1.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales by Manufacturers
      • 3.1.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Market Share by Manufacturers
      • 3.1.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Concentration Ratio (CR5 and HHI)
    • 3.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Manufacturers
      • 3.2.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Manufacturers (2014-2019)
      • 3.2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Manufacturers (2014-2019)
    • 3.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Price by Manufacturers
    • 3.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Manufacturing Base Distribution, Product Types
      • 3.4.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Type
      • 3.4.3 Date of International Manufacturers Enter into Transient Receptor Potential Cation Channel Subfamily V Member 1 Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales by Product
    • 4.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Product
    • 4.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Breakdown Data by End User

    6 North America

    • 6.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 by Countries
      • 6.1.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales by Countries
      • 6.1.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 by Product
    • 6.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 by End User

    7 Europe

    • 7.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 by Countries
      • 7.1.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales by Countries
      • 7.1.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 by Product
    • 7.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 by Countries
      • 8.1.1 Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales by Countries
      • 8.1.2 Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 by Product
    • 8.3 Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 by End User

    9 Central & South America

    • 9.1 Central & South America Transient Receptor Potential Cation Channel Subfamily V Member 1 by Countries
      • 9.1.1 Central & South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales by Countries
      • 9.1.2 Central & South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Transient Receptor Potential Cation Channel Subfamily V Member 1 by Product
    • 9.3 Central & South America Transient Receptor Potential Cation Channel Subfamily V Member 1 by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 by Countries
      • 10.1.1 Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales by Countries
      • 10.1.2 Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 by Product
    • 10.3 Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 by End User

    11 Company Profiles

    • 11.1 Amgen Inc
      • 11.1.1 Amgen Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Products Offered
      • 11.1.5 Amgen Inc Recent Development
    • 11.2 Amorepacific Corp
      • 11.2.1 Amorepacific Corp Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Products Offered
      • 11.2.5 Amorepacific Corp Recent Development
    • 11.3 BCN Peptides SA
      • 11.3.1 BCN Peptides SA Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Products Offered
      • 11.3.5 BCN Peptides SA Recent Development
    • 11.4 Centrexion Therapeutics Corp
      • 11.4.1 Centrexion Therapeutics Corp Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Products Offered
      • 11.4.5 Centrexion Therapeutics Corp Recent Development
    • 11.5 Daewoong Pharmaceutical Co Ltd
      • 11.5.1 Daewoong Pharmaceutical Co Ltd Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Products Offered
      • 11.5.5 Daewoong Pharmaceutical Co Ltd Recent Development
    • 11.6 DoNatur GmbH
      • 11.6.1 DoNatur GmbH Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Products Offered
      • 11.6.5 DoNatur GmbH Recent Development
    • 11.7 Flex Pharma Inc
      • 11.7.1 Flex Pharma Inc Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Products Offered
      • 11.7.5 Flex Pharma Inc Recent Development
    • 11.8 Grunenthal GmbH
      • 11.8.1 Grunenthal GmbH Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Products Offered
      • 11.8.5 Grunenthal GmbH Recent Development
    • 11.9 Kyowa Hakko Kirin Co Ltd
      • 11.9.1 Kyowa Hakko Kirin Co Ltd Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Products Offered
      • 11.9.5 Kyowa Hakko Kirin Co Ltd Recent Development
    • 11.10 Medifron DBT Co Ltd
      • 11.10.1 Medifron DBT Co Ltd Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Products Offered
      • 11.10.5 Medifron DBT Co Ltd Recent Development
    • 11.11 Neurim Pharmaceuticals Ltd
    • 11.12 Pila Pharma AB
    • 11.13 Sylentis SAU
    • 11.14 Toray Industries Inc
    • 11.15 Vitality Biopharma Inc

    12 Future Forecast

    • 12.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast by Regions
      • 12.1.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Forecast by Regions 2019-2025
    • 12.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast by Product
      • 12.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Forecast by Product 2019-2025
      • 12.2.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Forecast by Product 2019-2025
    • 12.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast by End User
    • 12.4 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast
    • 12.5 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast
    • 12.6 Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast
    • 12.7 Central & South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast
    • 12.8 Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Transient Receptor Potential Cation Channel Subfamily V Member 1 market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Transient Receptor Potential Cation Channel Subfamily V Member 1 market based on company, product type, end user and key regions.

      This report studies the global market size of Transient Receptor Potential Cation Channel Subfamily V Member 1 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Transient Receptor Potential Cation Channel Subfamily V Member 1 in these regions.
      This research report categorizes the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market by top players/brands, region, type and end user. This report also studies the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Amgen Inc
      Amorepacific Corp
      BCN Peptides SA
      Centrexion Therapeutics Corp
      Daewoong Pharmaceutical Co Ltd
      DoNatur GmbH
      Flex Pharma Inc
      Grunenthal GmbH
      Kyowa Hakko Kirin Co Ltd
      Medifron DBT Co Ltd
      Neurim Pharmaceuticals Ltd
      Pila Pharma AB
      Sylentis SAU
      Toray Industries Inc
      Vitality Biopharma Inc

      Market size by Product
      CMX-020
      CA-016
      DD-04107
      Others
      Market size by End User
      Ophthalmology
      Immunology
      Muscle Spasm
      Pruritus
      Abdominal Pain
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Transient Receptor Potential Cation Channel Subfamily V Member 1 market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Transient Receptor Potential Cation Channel Subfamily V Member 1 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Transient Receptor Potential Cation Channel Subfamily V Member 1 submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Transient Receptor Potential Cation Channel Subfamily V Member 1 are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Transient Receptor Potential Cation Channel Subfamily V Member 1 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now